Cargando…
P804: PLASMA CELL LEUKEMIA-LIKE TRANSCRIPTOME OF BONE MARROW PLASMA CELLS AND CIRCULATING TUMOR CELL LEVELS IN PERIPHERAL BLOOD COMPLEMENTARILY DEFINE HIGH-RISK IN NEWLY DIAGNOSED MULTIPLE MYELOMA
Autores principales: | D’agostino, Mattia, Bruinink, Davine Hofste Op, van Duin, Mark, Rota-Scalabrini, Delia, Bertamini, Luca, Kuiper, Rowan, Belotti, Angelo, Marasco, Vincenzo, Oliva, Stefania, Rivolti, Elena, Rogers, Jennifer, Mina, Roberto, Grasso, Mariella, Ledda, Antonio, Offidani, Massimo, Galli, Monica, Cavo, Michele, Broijl, Annemiek, Musto, Pellegrino, Bruno, Benedetto, Boccadoro, Mario, Sonneveld, Pieter, Gay, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430549/ http://dx.doi.org/10.1097/01.HS9.0000970120.36094.ab |
Ejemplares similares
-
Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile
por: Hofste op Bruinink, Davine, et al.
Publicado: (2022) -
Standardization of flow cytometric minimal residual disease assessment in international clinical trials. A feasibility study from the European Myeloma Network
por: op Bruinink, Davine Hofste, et al.
Publicado: (2020) -
B05 PLASMA CELL LEUKEMIA-LIKE STATUS HAS INDEPENDENT PROGNOSTIC VALUE IN THE CONTEXT OF THE SECOND REVISION OF THE INTERNATIONAL STAGING SYSTEM
por: Hofste op Bruinink, D., et al.
Publicado: (2023) -
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial
por: Oliva, Stefania, et al.
Publicado: (2021) -
Myosin and tropomyosin–troponin complementarily regulate thermal activation of muscles
por: Ishii, Shuya, et al.
Publicado: (2023)